BioEphX develops therapeutics that preserve tissue viability and performance following myocardial infarction.
Company Details
Company type
Year founded
2020
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)
Products under development
EFNA1, a therapeutic that restores heart tissue damaged by heart attacks and congestive heart failure and a surgical adjuvant to CABG